Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.
- Published in:
- European Journal of Rheumatology, 2018, v. 5, n. 4, p. 272, doi. 10.5152/eurjrheum.2018.18040
- By:
- Publication type:
- Article
Works by Treadwell, Edward L.
Results: 6
1
2
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.
- Published in:
- European Journal of Rheumatology, 2018, v. 5, n. 3, p. 153, doi. 10.5152/eurjrheum.2018.18040
- By:
- Publication type:
- Article
3
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 5, p. 1, doi. 10.1186/ar4318
- By:
- Publication type:
- Article
4
Physicians and Advanced Practice Registered Nurses: Working Together As a Team.
- Published in:
- North Carolina Medical Journal, 2012, v. 73, n. 2, p. 147, doi. 10.18043/ncm.73.2.147
- By:
- Publication type:
- Article
5
Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T.
- Published in:
- 2015
- By:
- Publication type:
- journal article
6
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 7, p. 711, doi. 10.1001/jama.2011.1169
- By:
- Publication type:
- Article